Equitable Care During Incarceration

Authors

Lisa M. Taylor, University of New Mexico, College of Nursing
Clarissa Spiro, University of New Mexico, College of Nursing

Files

Document Type

Poster

Publication Date

7-12-2024

Abstract

There are over 2 million people in the varied US detention centers including state and federal prisons, local jails, juvenile detention facilities, Indian Country jails, military prisons, immigration detention facilities, and civil commitment centers., with an estimated 9% living with diabetes where the US average is 10% (ADA position statement, 2021). The Metropolitan Detention Center (MDC) is the largest behavioral health provider in Albuquerque, outside of the corrections facilities, but this jail also has acute and chronic care access for inmates, as well as addiction medicine. The population is vulnerable to gaps in care and poor health outcomes due to the nature of care available in a jail setting vs. a prison setting. One example is those patients living with diabetes (T1 or T2). The American Diabetes Association’ 2024 clinical guidelines outline the appropriate medications to begin when a patient is not meeting blood glucose level (BGL ) targets. The two classes of medications are known as SGLT-2’s and GLP1-RA’s, neither of which is available in MDC. What is critical is how to best manage those not meeting BGL targets with limited resources. How is evidence-grounded diabetes care to be delivered in a setting where the guidelines are not completely in place due to budget and other restrictions?

Keywords

diabetes, clinical guidelines, jail, health outcomes

Recommended Citation

Taylor, Lisa M. and Clarissa Spiro. "Equitable Care During Incarceration." (2024). https://digitalrepository.unm.edu/hsc_ipe_posters/29